ConductScience.org, home

Paper32145488

Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration.

Anastasio NC and 7 others. Neuropharmacology, 2020. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration. Papers, record 32145488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32145488

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration.
PubMed
Journal
Neuropharmacology
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.51
iCite
Revised in PubMed
2022-04-08
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Anastasio NCNoelle C
2Sholler DJDennis J
3Fox RGRobert G
4Stutz SJSonja J
5Merritt CRChristina R
6Bjork JMJames M
7Moeller FGF Gerard
8Cunningham KAKathryn A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BenzazepinesMajor topic
CocaineMajor topic
Cocaine-Related DisordersMajor topic
PiperidinesMajor topic
UreaMajor topic
Animals
Dose-Response Relationship, Drug
Drug Therapy, Combination
Male
Rats
Rats, Sprague-Dawley
Recurrence
Self Administration
Serotonin 5-HT2 Receptor Antagonists

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 DA033935NIDA NIH HHSUnited StatesP50DA033935PubMedNIH RePORTER
U54 DA038999NIDA NIH HHSUnited StatesU54DA038999PubMed and NIHNIH RePORTER

Download CSV of grants

References73

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126926963Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system.Neuroscience2016https://conductscience.org/library/papers/26926963PubMed
214627998Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats.Neuropsychopharmacology2004https://conductscience.org/library/papers/14627998PubMed
319397907(1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.Eur J Pharmacol2009https://conductscience.org/library/papers/19397907PubMed
428414422Synthesis and Structure-Activity Relationships of Tool Compounds Based on WAY163909, a 5-HT2C Receptor Agonist.ACS Chem Neurosci2017https://conductscience.org/library/papers/28414422PubMed
523939424Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence.Neuropsychopharmacology2014https://conductscience.org/library/papers/23939424PubMed
624618688Variation within the serotonin (5-HT) 5-HT₂C receptor system aligns with vulnerability to cocaine cue reactivity.Transl Psychiatry2014https://conductscience.org/library/papers/24618688PubMed
727475769Neurobiology of addiction: a neurocircuitry analysis.Lancet Psychiatry2016https://conductscience.org/library/papers/27475769PubMed
823946394Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates.J Neurosci2013https://conductscience.org/library/papers/23946394PubMed
926534942Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys.J Pharmacol Exp Ther2016https://conductscience.org/library/papers/26534942PubMed
1021079923Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats.Psychopharmacology (Berl)2011https://conductscience.org/library/papers/21079923PubMed
118912799Failure of ritanserin to block cocaine cue reactivity in humans.Drug Alcohol Depend1996https://conductscience.org/library/papers/8912799PubMed
1211082456Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior.J Pharmacol Exp Ther2000https://conductscience.org/library/papers/11082456PubMed
1321575646
Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues.
Neuropharmacology2011https://conductscience.org/library/papers/21575646PubMed
1412185211Addiction.Annu Rev Psychol2003https://conductscience.org/library/papers/12185211PubMed
1523850573Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.Neuropharmacology2014https://conductscience.org/library/papers/23850573PubMed
1622328576Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys.J Pharmacol Exp Ther2012https://conductscience.org/library/papers/22328576PubMed
1712377394
Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
Neuropsychopharmacology2002https://conductscience.org/library/papers/12377394PubMed
1812427861Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice.J Neurosci2002https://conductscience.org/library/papers/12427861PubMed
1929555153Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907.Bioorg Med Chem Lett2018https://conductscience.org/library/papers/29555153PubMed
2017653111The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues.Neuropsychopharmacology2008https://conductscience.org/library/papers/17653111PubMed

See all 73 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
40749271Lorcaserin modulation of semantic drug cue-elicited effective brain connectivity in persons with cocaine and opioid use disorders.Psychiatry Res Neuroimaging2025https://conductscience.org/library/papers/40749271PubMed
40035828The psychedelic (-)-2,5-dimethoxy-4-iodoamphetamine [(-)-DOI] demonstrates efficacy in reducing cocaine reward and motivation in male rats.Psychopharmacology (Berl)2025https://conductscience.org/library/papers/40035828PubMed
39433903Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats.Mol Psychiatry2025https://conductscience.org/library/papers/39433903PubMed
39200714Chronic Cocaine Use and Parkinson's Disease: An Interpretative Model.Int J Environ Res Public Health2024https://conductscience.org/library/papers/39200714PubMed
39096558Novel therapeutics in development for the treatment of stimulant-use disorder.Curr Opin Neurobiol2024https://conductscience.org/library/papers/39096558PubMed
38677331Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice.Behav Brain Res2024https://conductscience.org/library/papers/38677331PubMed
366272043,4-Methylenedioxypyrovalerone High-Responder Phenotype as a Tool to Evaluate Candidate Medications for Stimulant Use Disorder.J Pharmacol Exp Ther2023https://conductscience.org/library/papers/36627204PubMed
36588704Heightened cocaine-seeking in male rats associates with a distinct transcriptomic profile in the medial prefrontal cortex.Front Pharmacol2022https://conductscience.org/library/papers/36588704PubMed
35221941Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice.Front Behav Neurosci2021https://conductscience.org/library/papers/35221941PubMed
35183539Sex-specific role for serotonin 5-HT2A receptor in modulation of opioid-induced antinociception and reward in mice.Neuropharmacology2022https://conductscience.org/library/papers/35183539PubMed
34916591Role of neuropeptide neuromedin U in the nucleus accumbens shell in cocaine self-administration in male rats.Neuropsychopharmacology2022https://conductscience.org/library/papers/34916591PubMed
34461148Confronting the challenge of failed translation in medications development for substance use disorders.Pharmacol Biochem Behav2021https://conductscience.org/library/papers/34461148PubMed
34454912Covid-19 interface with drug misuse and substance use disorders.Neuropharmacology2021https://conductscience.org/library/papers/34454912PubMed
33929084The 5-HT2C receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment-seeking individuals.Pharmacol Res Perspect2021https://conductscience.org/library/papers/33929084PubMed
33862029Converging vulnerability factors for compulsive food and drug use.Neuropharmacology2021https://conductscience.org/library/papers/33862029PubMed
333897975HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers.Addict Biol2021https://conductscience.org/library/papers/33389797PubMed
32839526Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder.Neuropsychopharmacology2020https://conductscience.org/library/papers/32839526PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32145488

GET https://conductscience.org/api/papers/v1/32145488/references?page=2